Riordan Compliance LLC

Panel Moderator, "Improve Internal Monitoring and Tracking of Off-label Requests," Off-label Guidelines: Appropriately Communicate Product Information to Mitigate Compliance Risk, sponsored by Center for Business Intelligence (Philadelphia, PA, June 22-23, 2012)

Lecturer, "Regulatory Issues Facing the Pharmaceutical Industry," Program in Pharmaceutical Management, Rutgers University Business School, Program in Pharmaceutical Management (New Brunswick, NJ, November 18, 2014)

Speaker, "FDA's 2014 Draft Social Media Guidances: The Good, the Bad & the Ugly," sponsored by FOI Services (Audioconference, August 26, 2014)

Speaker, "Progression of Corporate Integrity Agreements with Pharma, Biotech and Medical Device Companies," sponsored by International Society of Healthcare Ethics and Compliance Professionals (Webinar, March 20, 2014)

Lecturer, "Regulatory Issues Facing the Pharmaceutical Industry," Mini-MBA Program: Bio-Pharma Innovation, Rutgers University, Center for Management Development (New Brunswick, NJ, October 31, 2013)

Speaker, Preconference Workshop: "Pharmaceutical Compliance Basics," Fourteenth Annual Pharmaceutical Regulatory and Compliance Congress and Best Practices Forum (PharmaCongress), sponsored by Pharmaceutical Compliance Forum (Washington, DC, October 28, 2013)

Lecturer, "Regulatory Environment Facing the Pharmaceutical Industry," Program in Pharmaceutical Management, Rutgers University Business School, Program in Pharmaceutical Management (Newark, NJ, July 18, 2013)

Speaker, “Identifying and Addressing Risks for Executives and Individuals,” 14th Annual Forum on Off-Label Guidelines Conference, sponsored by Center for Business Intelligence (Philadelphia, PA, October 11-12, 2012)

Speaker, “Healthcare Compliance Issues: Preparing for 2012 and Beyond,” 2012 Annual Meeting, Healthcare Convention and Exhibitors Association (Orlando, FL, June 24, 2012)

Lecturer, “Regulatory Issues Facing the Pharmaceutical Industry,” Mini-MBA Program: Bio-Pharma Innovation, Rutgers University, Center for Management Development (June 20, 2012)

Speaker, “Handling Off-label Inquiries — A Cross-Disciplinary Effort,” Guidelines for Disseminating Off-label Information, Appropriately Communicate Product Information to Mitigate Compliance Risk, sponsored by Center for Business Intelligence (Arlington, VA, October 17-18, 2011)

Speaker, “How to Create an Effective Off-Label Compliance Program,” The A to Z of Off-Label Issues, sponsored by AdvaMed (Orlando, FL, January 26, 2011)

Speaker, “The Continuing Evolution of CIAs,” Eleventh Annual Pharmaceutical Regulatory and Compliance Congress and Best Practices Forum (PharmaCongress), sponsored by Pharmaceutical Compliance Forum (Washington, DC, October 20-22, 2010)

Speaker, “Building a Robust Compliance Program: Practical Solutions to Prevent Off-Label Violations,” sponsored by American Conference Institute (Philadelphia, PA, July 15, 2010)

Speaker, “Analyzing Implications of Recent Government Settlements: Trends and Compliance Considerations,” sponsored by Center for Business Intelligence (Webinar, July 14, 2010)

Speaker, “Off-label Promotion Mistakes: Protecting Yourself against Enforcement Actions,” sponsored by FOI Services (audioconference, June 24, 2010)

Speaker, “How to Create an Effective Off-Label Compliance Program,” The A to Z of Off-Label Issues, Medical Technology Learning Institute, AdvaMed (Washington, DC, March 30, 2010)

Speaker, “Evolution of CIAs and Reviewing New Corporate Integrity Obligations,”10th National Forum on Fraud and Abuse in the Sale and Marketing of Drugs, sponsored by American Conference Institute (New York, NY, March 24-25, 2010)

Speaker, “CME: Compliance Made Easy,” 6th Annual Pharmaceutical Meeting Management Forum, sponsored by Center for Business Intelligence and Medical Meetings Magazine (Philadelphia, PA, March 14-16, 2010)

Workshop Leader, “Optimization of Compliance Training Initiatives,” Seventh Annual Pharmaceutical Compliance Congress, sponsored by Center for Business Intelligence (Washington, DC, January 25-26, 2010)

Conference Co-Chair, 8th National Conference on Managing Legal Risks and Avoiding Conflicts of Interest in Medical Affairs, and Speaker, “Continuing Medical Education (CME) and Related Grant Challenges: Redesigning Current Practices to Comply With New Guidelines,” sponsored by American Conference Institute (Philadelphia, PA, December 7-8, 2009)

Speaker, “The Pfizer Civil, Criminal & Consumer Protection Settlements: What They Mean for You & Your Drug or Device Company,” sponsored by FOI Services (audioconference, October 7, 2009)

Speaker, “Off-Label Promotion Pitfalls for Drug & Device Firms: Advice from a Former Compliance Officer,” sponsored by FOI Services (audioconference, August 6, 2009)

Speaker, “Navigating the Federal and State Regulatory Environment for Pharmaceutical Meetings,” 5th Annual Pharmaceutical Meeting Management Forum, sponsored by Center for Business Intelligence and Medical Meetings (Baltimore, MD, March 30 - 31, 2009)

Speaker, “Compliant Grant Process,” Sixth Annual Pharmaceutical Compliance Congress, sponsored by Center for Business Intelligence (Washington, DC, January 26-27, 2009)

Speaker, Preconference Workshop: “Pharmaceutical Regulatory and Compliance Basics,” Ninth Annual Pharmaceutical Regulatory and Compliance Congress and Best Practices Forum (PharmaCongress), sponsored by Pharmaceutical Compliance Forum (Washington, DC, October 27-29, 2008)

Workshop Co-Leader, “State Reporting Compliance and Aggregate Spend: Everyone’s Responsibility,” 2nd Annual Forum on Tracking State Laws and Aggregate Spend, sponsored by Center for Business Intelligence (Washington, DC, August 13-14, 2008)

Speaker, “Modifying Compliance Programs in Response to Government Enforcement Activities,” Pharmaceutical & Medical Device Counsel’s Guide to Off-Label Communications, sponsored by American Conference Institute (Philadelphia, PA, July 16-17, 2008)

Speaker, “Integrating Investigation Preparedness into Existing Compliance Programs,” Internal Investigations for the Pharmaceutical, Medical Device and Life Sciences Industries, sponsored by American Conference Institute (Philadelphia, PA, June 24-25, 2008)

All-day Conference Chair and Speaker, “Developing and Executing a Strong Marketing Compliance Program,” Marketing Compliance for Pharma, sponsored by MarcusEvans (Philadelphia, PA, May 12, 2008)

Speaker, “Aggregate Spend,” HCPro (Webcast April 18, 2008)

Speaker, “Foster Compliance with the Professional Sales Force,” 8th National Forum on Fraud & Abuse in the Sale and Marketing of Drugs, sponsored by American Conference Institute (NY, NY, April 7-8, 2008)

Facilitator, Executive Exchange: “Overcoming Obstacles with Implementing State Tracking Systems,” Fifth Annual Pharmaceutical Marketing Compliance Congress, sponsored by Center for Business Intelligence (Washington, DC, January 28-29, 2008)

Panel Participant: “State Marketing, Ethics & Disclosure Laws: State Marketing Laws & Regulations,” Eighth Annual Pharmaceutical Regulatory and Compliance Congress and Best Practices Forum (PharmaCongress), sponsored by Pharmaceutical Compliance Forum (Washington, DC, November 7-9, 2007)

Panel Participant: “Divergent State Reporting Requirements: Combating Fraud & Abuse Allegations,” 7th National Forum on Fraud & Abuse in the Sale and Marketing of Drugs, sponsored by American Conference Institute (Philadelphia, PA, October 24-25, 2007)

Guest Lecturer, “Pharmaceutical Manufacturer Compliance,” Healthcare Compliance Certification Program, George Washington University (Alexandria, VA, March 9, 2007)

Moderator of day-long track, “State Laws for Sales, Marketing and Pricing,” Fourth Annual Pharmaceutical Marketing Compliance Congress, sponsored by Center for Business Intelligence (Washington, DC, January 30, 2007)

Moderator and Panel Participant of two sessions: “Approaches to Operating a Compliance Program with a Small Compliance Department” and“Monitoring and Tracking in Companies with Small Compliance Departments,” Seventh Annual Pharmaceutical Regulatory and Compliance Congress and Best Practices Forum (PharmaCongress), sponsored by Pharmaceutical Compliance Forum (Washington, DC, November 9, 2006)

Panel Participant, “Making the Move from Legal to Compliance,” Developing Leadership Skills to Move in Many Directions track, Women’s Health Law Forum, Georgetown University Law Center (Washington, DC, March 8, 2006)

Moderator of day-long track, “Off-Label Promotion,” Third Annual Pharmaceutical Marketing Compliance Congress, sponsored by Center for Business Intelligence (Washington, DC, January 31, 2006)

Presenter, “State Legislation: Complying with Current Requirements Regarding Gifts, Advertising & Marketing, and Compliance,” Fifth National Forum on Fraud & Abuse in the Sale and Marketing of Drugs, sponsored by American Conference Institute (New York, NY, October 24-25, 2005)

Conference Co-Chair and Presenter, “State Law Update--Gifts, Advertising and Marketing, and Compliance,” National Forum on Off-Label Promotion of Pharmaceuticals, sponsored by American Conference Institute (Philadelphia, PA, September 22-23, 2005)

Presenter, “Key Risk Areas: Business Courtesies and Off-Label Promotion,” Current Issues in Pharmaceutical and Medical Device Compliance Management, Pharma, Biotech and Device Colloquium: Advanced Executive Education on the Interface of Regulation and Business Strategy for Global Pharmaceutical, Biotechnology and Medical Device Enterprises (Princeton University, Princeton, NJ, June 6-8, 2005)

Conference Chair, “Fraud & Abuse: Sales, Marketing, and Pricing Compliance to Avoid Penalties,” sponsored by Pharmaceutical Education Associates (Washington, DC, March 21-22, 2005)

Presenter, “Risk Areas and Compliance Programs: Key Insights from In-House Compliance Professionals,” Pharma, Biotech and Device Colloquium: Advanced Executive Education on the Interface of Regulation and Business Strategy for Global Pharmaceutical, Biotechnology and Medical Device Enterprises (Princeton University, Princeton, NJ, June 8, 2004)